US FDA Drug Registration: Essential Compliance for Selling Drugs in the USA

Us fda drug register search, Us fda drug register pdf, Us fda drug register list, Us fda drug register online, Us fda drug register lookup, US FDA registration number search, FDA Drug database download, FDA drug establishment registration, How to check US FDA registration?, What is FDA registration in the USA?, How do I check if a drug is FDA approved?, How to check if a product is registered in FDA?, What is a 7 digit FDA product code?, How to check if a product is registered?, What is FDA called in India?, What are the 8 types of products regulated by the FDA?, What is the FDA drug number?

Selling drug products in the United States requires strict adherence to federal regulations. US FDA Drug Registration is a mandatory compliance process overseen by the U.S. Food and Drug Administration (FDA). Any company involved in manufacturing, processing, repacking, relabeling, or exporting drugs to the US must complete FDA registration and drug listing before entering the market.

Failure to comply can result in shipment detention, import refusal, or regulatory enforcement.

Why US FDA Drug Registration Is Mandatory

US FDA Drug Registration exists to give the FDA full visibility into:

Where drugs are manufactured or processed
Which drug products are supplied to the US market
Who is legally responsible for compliance

The requirement is established under the Federal Food, Drug, and Cosmetic Act (FD&C Act) and applies equally to US and foreign pharmaceutical companies.

US FDA Drug Registration is made up of two compulsory regulatory actions:

Drug Establishment Registration
FDA Drug Product Listing

Both must remain active at all times to maintain legal market access.

FDA Registration vs FDA Approval

A common misconception is that FDA registration equals FDA approval. These are not the same.

FDA Registration: Mandatory notification and compliance requirement
FDA Approval: Scientific and regulatory evaluation applicable only to specific drugs

Many legally marketed drugs in the US are registered and listed but not FDA-approved under formal approval pathways.

Who Must Complete FDA Drug Registration?

FDA drug registration applies to all entities involved in drug manufacturing and distribution, including:

Prescription drug manufacturers
Over-the-counter (OTC) drug manufacturers
Contract manufacturing organizations
Repackers and relabelers
Foreign drug manufacturers exporting to the US

Foreign companies must also appoint a US Agent, who acts as the FDA’s authorized representative for inspections and official communication.

Drug Establishment Registration Requirements

Each physical location involved in drug manufacturing or processing must be registered separately with the FDA.

Key Regulatory Points

Registration is mandatory and renewed annually
Renewal window: October 1 to December 31
Applies to both domestic and foreign facilities
Required before importation or commercial distribution

Missing the renewal deadline can result in inactive registration and disruption of US shipments.

FDA Drug Listing and SPL Filing

After establishment registration, every drug product supplied to the US must be listed with the FDA.

Drug listing submissions contain detailed product information, including:

Drug name (brand and generic)
Dosage form and strength
Route of administration
Manufacturer and labeler details
National Drug Code (NDC)
Product labeling data

Listings must be submitted electronically using Structured Product Labeling (SPL) format. Even small inconsistencies between SPL data and product labels can trigger FDA correction requests.

National Drug Code (NDC): Compliance Impact

The National Drug Code (NDC) is a unique identifier assigned to each listed drug product. Although the FDA does not approve NDC numbers, correct NDC configuration is critical for:

Distribution through US supply chains
Pharmacy and hospital databases
Insurance reimbursement systems
Import and export documentation

Incorrect NDC assignment is one of the most frequent causes of FDA listing delays.

Additional Obligations for Foreign Manufacturers

Foreign pharmaceutical companies face extra compliance responsibilities, such as:

Appointment and maintenance of a US Agent
FDA inspection readiness outside the United States
Import compliance coordination
Alignment between registration, listing, and shipping documents

Any mismatch in data can result in import alerts or shipment holds at US ports.

Why Expert FDA Registration Support Matters

FDA drug registration involves regulatory interpretation, technical submissions, and continuous compliance monitoring. Errors can lead to delays, enforcement actions, or loss of market access.

XPRO America, a US FDA Consultancy, provides complete FDA drug registration and listing support for pharmaceutical companies worldwide. Their services include establishment registration, SPL preparation, drug listing submissions, NDC configuration, US Agent services, and annual renewal management.

Organizations seeking structured FDA compliance assistance can contact the regulatory team at support@xproamerica.com to discuss specific regulatory and market-entry requirements.

Conclusion

US FDA Drug Registration is a non-negotiable requirement for supplying drugs to the American market. While administrative in appearance, it demands precision, regulatory expertise, and ongoing maintenance.

By ensuring accurate FDA establishment registration and drug listing—and partnering with an experienced US FDA consultancy—companies can reduce compliance risk, avoid regulatory delays, and operate confidently within the US pharmaceutical marketplace.